Value proposition

AI-ImmunologyTM Powered Vaccines

Evaxion Biotech A/S is a pioneering TechBio company based upon its AI platform, AI-ImmunologyTM. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-ImmunologyTM, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients’ lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-ImmunologyTM platform and vaccine pipeline, please visit our website.

Immunoinformatics, Bioinformatics, Infectious Diseases, Immuno-Oncology, Vaccines, Immunotherapy, Artificial Intelligence, Antigen Discovery, Neo Epitope Discovery, AI-Immunology, AI, and Biotech